Abstract
Tissue transglutaminase antibodies have not previously been measured in gut secretions. IgA anti-tissue transglutaminase and anti-endomysium antibodies were measured in paired serum and whole gut lavage fluid samples from patients with untreated celiac disease (N = 36), other gastrointestinal diseases (N = 235), and healthy volunteers (N = 13). HLA DQ2 typing was performed in the celiac patients. Whole gut lavage IgA anti-tissue transglutaminase antibody concentrations were raised in 83% of celiac patients, 4% of disease controls, and 8% of volunteers, and the antibody concentrations were significantly higher in celiac patients than in controls (P < 0.0001). Whole gut lavage IgA anti-endomysium antibodies were positive in 67% of celiac patients, but in none of the controls. Whole gut lavage, but not serum, IgA anti-tissue transglutaminase antibody concentrations were significantly higher in DQ2 positive than negative celiac patients. In conclusion, whole gut lavage IgA anti-tissue transglutaminase antibody concentrations are higher in untreated celiac disease than in other gastrointestinal diseases.
Similar content being viewed by others
REFERENCES
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D.: Identification of tissue transglutaminase as the autoantigen of coeliac disease. Nat Med 3(7):797–801, 1997
Sulkanen S, Halttunen T, Laurila K, Kolho K, Korponay-Szabo IL, Sarnesto A, Savilahti E, Collin P, Maki M: Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115(6):1322–1328, 1998
Dieterich W, Laag E, Schopper H, Volta U, Ferguson A, Gillett H, Riecken EO, Schuppan D: Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115(6):1317–1321, 1998
Lock RJ, Pitcher MCL, Unsworth DJ: IgA tissue transglutaminase as a diagnostic marker of gluten sensitive enteropathy. J Clin Pathol 52:274–277, 1999
Troncone R, Maurano F, Rossi M, Micillo M, Greco L, Auricchio S, Salerno G, Salvatore F, Sacchetti L: IgA antibodies to tissue transglutaminase: An effective diagnostic test for celiac disease. J Pediatr 134:166–171, 1999
Biagi F, Ellis HJ, Yiannakou JY, Brusco G, Swift GL, Smith PM, Corazza GR, Ciclitira PJ: Tissue transglutaminase antibodies in celiac disease. Am J Gastroenterol 94(8):2187–2192, 1999
Folk JE: Structure and catalytic properties of hepatic transglutaminase. Ann NY Acad Sci 202:59–76, 1972
Upchurch HF, Conway E, Patterson MK Jr., Birckbichler PJ, Maxwell MD: Cellular transglutaminase has affinity for extracellular matrix. In Vitro Cell Dev Biol 23(11):795–799, 1987
Patel EK, Bruce SE, Bjarnason I, Peters TJ: Rat gastrointestinal transglutaminase: Demonstration of enzyme activity and cell and tissue distributions. Cell Biochem Funct 3:199–203, 1985
Bruce SE, Bjarnason I, Peters TJ: Human jejunal transglutaminase: Demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Clin Sci 68:573–579, 1985
Molberg O, Mcadam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KEA, Sjostrom H, et al: Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gutderived T cells in celiac disease. Nat Med 4(6):713–717, 1998
Lundin KEA, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, Thorsby E, Sollid LM: Gliadin-specific, HLADQ( a1*0501, b1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 178:187–196, 1993
Molberg O, Kett K, Scott H, Thorsby E, Sollid LM, Lundin KEA: Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol 46:103–108, 1997
Sollid LM, Molberg O, McAdam S, Lundin KEA: Autoantibodies in coeliac disease: Tissue transglutaminase–guilt by association? Gut 41:851–852, 1997
O'Mahony S, Arranz E, Barton JR, Ferguson A: Dissociation between systemic and mucosal humoral immune responses in coeliac disease. Gut 32(1):29–35, 1991
Challacombe SJ. Assessing mucosal humoral immunity. Clin Exp Immunol 100:181–182, 1995
O'Mahony S, Barton JR, Crighton S, Ferguson A: Appraisal of gut lavage in the study of intestinal humoral immunity. Gut 31:1341–1344, 1990
Choudari CP, O'Mahony S, Brydon G, Mwantembe O, Ferguson A: Gut lavage fluid protein concentrations: Objective measures of disease activity in inflammatory bowel disease. Gastroenterology 104(4):1064–1071, 1993
Brydon WG, Choudari CP, Ferguson A: Relative specificity for active inflammatory bowel disease of plasma-derived proteins in gut lavage fluid. Eur J Gastroenterol Hepatol 5:269–273, 1993
Gaspari MM, Brennan PT, Solomon SM, Elson CO: A method of obtaining, processing, and analyzing human intestinal secretions for antibody content. J Immunol Methods 110:85–91, 1988
Brown WR, Newcomb RW, Ishizaka K: Proteolytic degradation of exocrine and serum immunoglobulins. J Clin Invest 49:1374–1380, 1970
Jones RG, Payne RB: Data for diagnosis and monitoring. In Clinical Investigation and Statistics in Laboratory Medicine. RG Jones, RB Payne, (eds). London, ACB Venture, 1997, pp. 66–123
Bell JL, Todd JA, McDevitt HO: The molecular basis of HLA-disease association. Adv Hum Genet 18:1–41, 1989
Larhammar D, Hyldig-Nielsen JJ, Servenius B: Exon-intron organization and complete nucleotide sequence of a human major histocompatibility antigen DC beta gene. Proc Natl Acad Sci USA 95:78–82, 1983
Kelly CP, Feighery C, Gallagher RB, Gibney MJ, Weir DG: Mucosal and systemic IgA anti-gliadin antibody in celiac disease. Contrasting patterns of response in serum, saliva, and intestinal secretions. Dig Dis Sci 36(6):743–751, 1991
Engstrom PE, Sundin U, Lavo B, Norhagen G, Hallgren R, Smith CIE: Class and subclass-associated specificity differences of anti-gliadin antibodies from mucosa and serum. Immunology 77:604–608, 1992
Lancaster-Smith M, Kumar P, Marks R, Clark ML, Dawson AM: Jejunal mucosal immunoglobulin-containing cells and jejunal fluid immunoglobulins in adult coeliac disease and dermatitis herpetiformis. Gut 15:371–376, 1974
Volta U, Molinaro N, Fratangelo D, Bianchi FB: IgA subclass antibodies to gliadin in serum and intestinal juice of patients with coeliac disease. Clin Exp Immunol 80:192–195, 1990
Mwantembe O: The immunological effects of elemental diets in inflammatory bowel disease. Edinburgh, University of Edinburgh, 1992, 179 pp
Colombel JF, Mascart-Lemone F, Nemeth J, Vaerman JP, Dive C, Rambaud JC: Jejunal immunoglobulin and antigliadin antibody secretion in adult coeliac disease. Gut 31:1345–1349, 1990
Crabbe PA, Carbonara AO, Heremans JF: The normal human intestinal mucosa as a major source of plasma cells containing gamma-A-immunoglobulin. Lab Invest 14(3):235–248, 1965
Rosekrans PCM, Meijer CJLM, Van Der Wal AM, Cornelisse CJ, Lindeman J: Immunoglobulin containing cells in inflammatory bowel disease of the colon: A morphometric and immunohistochemical study. Gut 21:941–947, 1980
Ferguson A, Humphreys K, Croft N. Technical reports: Results of immunological tests on faecal extracts are likely to be extremely misleading. Clin Exp Immunol 99:70–75, 1995
Collin P, Maki M, Keyrilainen O, Hallstrom O, Reunala T, Pasternack A: Selective IgA deficiency and coeliac disease. Scand J Gastroenterol 27:367–371, 1992
Webster ADB, Slavin G, Shiner M, Platts-Mills TAE, Asherson GL: Coeliac disease with severe hypogammaglobulinaemia. Gut 22:153–157, 1981
Halttunen T, Maki M: Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 116:566–572, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dahele, A., Aldhous, M.C., Kingstone, K. et al. Gut Mucosal Immunity to Tissue Transglutaminase in Untreated Celiac Disease and Other Gastrointestinal Disorders. Dig Dis Sci 47, 2325–2335 (2002). https://doi.org/10.1023/A:1020155831849
Issue Date:
DOI: https://doi.org/10.1023/A:1020155831849